Logo
Eine Ebene nach oben
Exportieren als [feed] RSS 1.0 [feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 13 .

Zeitschriftenartikel

D’Haese, Jan Goesta; Neumann, J.; Weniger, Maximilian; Pratschke, S.; Bjornsson, B.; Ardiles, V.; Chapman, W.; Hernandez-Alejandro, R.; Soubrane, O.; Robles-Campos, R.; Stojanovic, M.; Dalla Valle, R.; Chan, A. C.; Coenen, Michaela; Guba, M.; Werner, Jens; Schadde, E.; Angele, Martin Kurt (2016): Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC? In: Annals of Surgical Oncology, Vol. 23, Nr. 4: S. 1335-1343

Michl, M.; Heinemann, V.; Jung, A.; Engel, Jutta; Kirchner, T.; Neumann, J. (2015): Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system. In: Pathology, Research and Practice, Vol. 211, Nr. 8: S. 601-609

Michl, M.; Thurmaier, J.; Schubert-Fritschle, Gabriele; Wiedemann, Max; Laubender, Rüdiger P.; Nussler, N. C.; Ruppert, R.; Kleeff, J.; Schepp, W.; Reuter, C.; Lohe, F.; Karthaus, M.; Neumann, J.; Kirchner, T.; Engel, Jutta; Heinemann, V. (2015): Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors. In: Clinical Colorectal Cancer, Vol. 14, Nr. 4: S. 281-290

Stahler, A.; Heinemann, V.; Giessen-Jung, C.; Crispin, Alexander; Schalhorn, A.; Stintzing, S.; Fischer von Weikersthal, L.; Vehling-Kaiser, U.; Stauch, M.; Quietzsch, D.; Held, S.; Einem, J. C. von; Holch, J.; Neumann, J.; Kirchner, T.; Jung, A.; Modest, D. P. (2015): Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial). In: International Journal of Cancer, Vol. 138, Nr. 3: S. 739-746

Neumann, J.; Wehweck, L.; Maatz, S.; Engel, Jutta; Kirchner, T.; Jung, A. (2013): Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis. In: Virchows Archiv, Vol. 463, Nr. 4: S. 509-523

Siemens, H.; Neumann, J.; Jackstadt, R.; Mansmann, Ulrich; Horst, D.; Kirchner, T.; Hermeking, H. (2013): Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer. In: Clinical Cancer Research, Vol. 19, Nr. 3: S. 710-720

Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Ormanns, S.; Haas, M.; Modest, D. P.; Kirchner, T.; Heinemann, V. (2013): KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer. In: Journal of Gastroenterology, Vol. 48, Nr. 4: S. 544-548

Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Vehling-Kaiser, U.; Winkelmann, C.; Fischer von Weikersthal, L.; Clemens, M. R.; Gauler, T. C.; Marten, A.; Klein, S.; Kojouharoff, G.; Barner, M.; Geissler, M.; Greten, T. F.; Mansmann, Ulrich; Kirchner, T.; Heinemann, V. (2013): EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. In: British Journal of Cancer BJC, Vol. 108, Nr. 2: S. 469-476

Neumann, J.; Horst, D.; Kriegl, L.; Maatz, S.; Engel, Jutta; Jung, A.; Kirchner, T. (2012): A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer. In: Histopathology, Vol. 60, Nr. 3: S. 416-426

Modest, D. P.; Jung, A.; Moosmann, N.; Laubender, Rüdiger P.; Giessen, C.; Schulz, C.; Haas, M.; Neumann, J.; Boeck, S.; Kirchner, T.; Heinemann, V.; Stintzing, S. (2012): The influence of KRAS- and BRAF-mutations on the efficacy of cetuximab-based 1st-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104 -trial. In: International Journal of Cancer, Vol. 131, Nr. 4: S. 980-986

Modest, D. P.; Stintzing, S.; Laubender, Rüdiger P.; Neumann, J.; Jung, A.; Giessen, C.; Haas, M.; Aubele, P.; Schulz, C.; Boeck, S.; Stemmler, H. J.; Kirchner, T.; Heinemann, V. (2011): Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status. In: Anticancer Drugs, Vol. 22, Nr. 9: S. 913-918

Herbst, A.; Rahmig, K.; Stieber, P.; Philipp, A.; Jung, A.; Ofner, A.; Crispin, Alexander; Neumann, J.; Lamerz, R.; Kolligs, F. T. (2011): Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. In: American Journal of Gastroenterology, Vol. 106, Nr. 6: S. 1110-1118

Habermann, J.; Heinze, H. G.; Horn, K.; Kantlehner, R.; Marschner, I.; Neumann, J.; Scriba, Peter Christian (1975): Alimentärer Jodmangel in der Bundesrepublik Deutschland. In: Deutsche medizinische Wochenschrift, Vol. 100: S. 1937-1945 [PDF, 3MB]

Diese Liste wurde am Tue May 30 05:08:49 2017 CEST erstellt.